ArticleViruses2022

Activity of a Carbohydrate-Binding Module Therapy, Neumifil, against SARS-CoV-2 Disease in a Hamster Model of Infection.

Rachel Fell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.